Healthia (ASX:HLA) is projected to have FY23 revenue between $253.0M-$254.0M.
The company has achieved 6.2% organic revenue growth for July.
The firm continues to set goals for an annual organic revenue growth between 3.0%-6.0%.
Furthermore, Healthia predicts their EBITDA(U) to range from A$38.0M to A$39.0M for FY23.Healthia (ASX:HLA) is a company specializing in the field of healthcare, with several services to offer.